［1］ ZAVROS Y,MERCHANT JL.The immune microenvironment in gastric adenocarcinoma［J］.Nat Rev Gastroenterol Hepatol,2022,19(7):451-467.
［2］ 苗智峰,徐忠法,王振宁,等.胃癌早诊早治中国专家共识（2023版）［J］.中国消化外科杂志,2024,23(1):23-36.
MIAO ZF,XU ZF,WANG ZN,et al.Chinese expert consensus on early diagnosis and treatment of gastric cancer (2023 edition)［J］.Chin J Dig Surg,2024,23(1):23-36.
［3］ GUAN WL,HE Y,XU ＲH.Gastric cancer treatment:recent progress and future perspectives［J］.J Hematol Oncol,2023,16(1):57.
［4］ SUZUKI S,TAKAHASHI A,ISHIKAWA T,et al．Surgically treated gastric cancer in Japan:2011 annual report of the national clinical database gastric cancer registry［J］.Gastric Cancer,2021,24(3):545-566．
［5］ GREIL C,ENGELHARDT M,WASCH R.The role of the APC/C and its coactivators Cdh1 and Cdc20 in cancer development and therapy［J］.Front Genet,2022,13:941565.
［6］ PIANO V,ALEX A,STEGE P,et al.CDC20 assists its catalytic incorporation in the mitotic checkpoint complex［J］.Science,2021,371(6524):67-71.
［7］ DU YG,DENG T,CHENG YH,et al.Enhancing bone regeneration through CDC20-loaded ZIF-8 nanoparticles wrapped in erythrocyte membranes with targeting aptamer［J］.Adv Healthc Mater,2024,13(7):e2302725.
［8］ HE W,MENG J.CDC20:a novel therapeutic target in cancer［J］.Am J Transl Res,2023,15(2):678-693.
［9］ CAO Y,LIANG HB,ZHANG F,et al.Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer［J］.J Exp Clin Cancer Res,2016,35:68.
［10］ OKAMOTO T,SUZUKI H,FUKUDA K.Simultaneous gastric cancer and breast cancer metastases to the stomach with lymph node collision tumor:a case report［J］.BMC Gastroenterol,2021,21(1):240.
［11］ LE JH,PAN GZ,ZHANG CH,et al.Targeting ferroptosis in gastric cancer:Strategies and opportunities［J］.Immunol Rev,2024,321(1):228-245.
［12］ TSANG MJ,CHEESEMAN LM.Alternative CDC20 translational isoforms tune mitotic arrest duration［J］.Nature,2023,617(7959):154-161.
［13］ ZHENG W,ZHAO YB,WANG TS,et al.Identification of hub genes associated with bladder cancer using bioinformatic analyses［J］.Transl Cancer Res,2022,11(5):1330-1343.
［14］ DAS A,SHARMA HK,LATHER V,et al.Structure-based virtual screening for identification of potential CDC20 inhibitors and their therapeutic evaluation in breast cancer［J］.3 Biotech,2023,13(5):141.
［15］ JEONG SM,BUI QT,KWAK M,et al.Targeting Cdc20 for cancer therapy［J］.Biochim Biophys Acta BBA Rev Cancer,2022,1877(6):188824.
［16］ YANG CL,GE YG,ZANG YC,et al.CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression［J］.Apoptosis,2023,28(11-12):1584-1595.
［17］ BRUNO S,RORA AGL,NAPOLITANO R,et al.CDC20 in and out of mitosis:a prognostic factor and therapeutic target in hematological malignancies［J］.J Exp Clin Cancer Res,2022,41(1):159.
［18］ ZHANG QL,WANG YM,XUE FX.ASPM,CDC20,DLGAP5,BUB1B,CDCA8,and NCAPG may serve as diagnostic and prognostic biomarkers in endometrial carcinoma［J］.Genet Res(Camb),2022,2022:3217248.
［19］ DING ZY,WU HR,ZHANG JM,et al.Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis［J］.Int J Clin Exp Pathol,2014,7(2):722-727.